Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | N/A | $82,584 | $19,996 | $85,159 | $88,821 |
| Gross Profit | N/A | $54,157 | $13,824 | $58,606 | $61,350 |
| Operating Income | N/A | N/A | N/A | N/A | N/A |
| Net Income | N/A | $14,714 | $4,458 | $35,153 | $14,066 |
Over the five-year period, the data suggest a volatile financial performance for Johnson & Johnson. Although 2020 appears non-informative with all zeros, 2021 shows robust performance with revenue of $82,584 million and a gross profit of $54,157 million. However, 2022 saw a dramatic decline—with revenue plunging to $19,996 million and gross profit to $13,824 million—representing year-over-year drops of roughly 76% and 74%, respectively. Net income also fell sharply by nearly 70%, from $14,714 million in 2021 to $4,458 million in 2022. Notably, operating income figures were not provided, which limits a full understanding of the company’s operating efficiency during these years. The recovery that followed is mixed. In 2023, revenue rebounded to $85,159 million and gross profit increased to $58,606 million, with net income surging impressively to $35,153 million—a significant turnaround from the prior year. However, by 2024, while revenue and gross profit continued their upward trend to $88,821 million and $61,350 million respectively, net income fell back to $14,066 million, indicating a drop of about 60% from 2023. These swings, particularly the extreme contraction in 2022 and the volatile net income trends, could be driven by factors such as shifts in market demand, operational restructuring, or changes in non-operating items, though the provided data do not specify the causes. Overall, while the revenue and gross profit recovery appear promising, the inconsistent net income and missing operating income data call for careful scrutiny of internal cost management and external market factors to assess the company’s sustainable financial health.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.